Vaccines E-Book
1570Vaccines E-Book
1570eBook
Related collections and offers
Overview
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
- Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability.
- Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
- Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
- Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
- Analyze the cost-benefit and cost-effectiveness of different vaccine options.
- Clearly visualize concepts and objective data through an abundance of tables and figures.
- Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
- Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
Product Details
ISBN-13: | 9781455737987 |
---|---|
Publisher: | Elsevier Health Sciences |
Publication date: | 09/22/2012 |
Sold by: | Barnes & Noble |
Format: | eBook |
Pages: | 1570 |
File size: | 143 MB |
Note: | This product may take a few minutes to download. |
About the Author
Table of Contents
Contents
Foreword ix
Preface to the first edition x
Preface to the sixth edition x
Preface by Editor in Chief xi
List of Contributors xii
Dedication xix
Acknowledgements xix
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
Susan L. Plotkin, Stanley A. Plotkin
2 Vaccine immunology 14
Claire-Anne Siegrist
3 The vaccine industry 33
R. Gordon Douglas, Vijay B. Samant
4 Vaccine manufacturing 44
Phillip L. Gomez, James M. Robinson, Joseph A. Rogalewicz
5 Evolution of adjuvants across the centuries 58
Nathalie Garçon, Stanley Hem, Martin Friede
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
Theresa M. Finn, William Egan
7 Passive immunization 80
E. Richard Stiehm, Margaret A. Keller
8 General immunization practices 88
Andrew T. Kroger, William L. Atkinson, Larry K. Pickering
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
Gregory C. Gray
10 Anthrax vaccines 127
Arthur M. Friedlander, John D. Grabenstein, Phillip S. Brachman
11 Cholera vaccines 141
John D. Clemens, Sunheang Shin, Binod K. Sah, David A. Sack
12 Diphtheria toxoid 153
Tejpratap S. P. Tiwari, Melinda Wharton
13 Haemophilus influenzae vaccines 167
Aruna Chandran, James P. Watt, Mathuram Santosham
14 Hepatitis A vaccines 183
Trudy V. Murphy, Stephen M. Feinstone, Beth P. Bell
15 Hepatitis B vaccines 205
Pierre Van Damme, John Ward, Daniel Shouval, Steven Wiersma, Alessandro Zanetti
16 Human papillomavirus vaccines 235
John T. Schiller, Douglas R. Lowy, Lauri E. Markowitz
17 Inactivated influenza vaccines 257
Anthony E. Fiore, Carolyn B. Bridges, Jacqueline M. Katz, Nancy J. Cox
18 Influenza vaccine—live 294
Catherine J. Luke, Seema S. Lakdawala, Kanta Subbarao
19 Japanese encephalitis vaccines 312
Scott B. Halstead, Julie Jacobson, Katrin Dubischar-Kastner
20 Measles vaccines 352
Peter M. Strebel, Mark J. Papania, Amy Parker Fiebelkorn, Neal A. Halsey
21 Meningococcal vaccines 388
Dan M. Granoff, Stephen Pelton, Lee H. Harrison
22 Mumps vaccine 419
Steven A. Rubin, Stanley A. Plotkin
23 Pertussis vaccines . 447
Kathryn M. Edwards, Michael D. Decker
24 Plague vaccines 493
E. Diane Williamson, Petra C. F. Oyston
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
Keith P. Klugman, Steven Black, Ron Dagan, Richard Malley, Cynthia G. Whitney
26 Pneumococcal polysaccharide vaccines 542
Lisa A. Jackson
27 Poliovirus vaccine—inactivated . 573
Emmanuel Vidor, Stanley A. Plotkin
28 Poliovirus vaccine—live 598
Roland W. Sutter, Olen M. Kew, Stephen L. Cochi, R. Bruce Aylward
29 Rabies vaccines .646
Charles E. Rupprecht, Stanley A. Plotkin
30 Rotavirus vaccines . 669
H. Fred Clark, Paul A. Offit, Umesh D. Parashar
31 Rubella vaccine 688
Susan E. Reef, Stanley A. Plotkin
32 Smallpox and vaccinia 718
Richard B. Kennedy, J. Michael Lane, Donald A. Henderson, Gregory A. Poland
33 Tetanus toxoid 746
Martha H. Roper, Steven G. F. Wassilak, Tejpratap S. P. Tiwari, Walter A. Orenstein
34 Tick-borne encephalitis virus vaccines 773
P. Noel Barrett, Daniel Portsmouth, Hartmut J. Ehrlich
35 Tuberculosis vaccines 789
Kim Connelly Smith, Ian M. Orme, Jeffrey R. Starke
36 Typhoid fever vaccines 812
Myron M. Levine
37 Varicella vaccine 837
Anne A. Gershon, Michiaki Takahashi, Jane F. Seward
38 Yellow fever vaccine 870
Thomas P. Monath, Mark Gershman, J. Erin Staples, Alan D. T. Barrett
39 Zoster vaccine 969
Myron J. Levin
40 Combination vaccines 981
Michael D. Decker, Kathryn M. Edwards, Hugues H. Bogaerts
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
Phillip R. Pittman, Stanley A. Plotkin
42 Therapeutic cancer vaccines 1018
Neil L. Berinstein, Jeffrey A. Berinstein
43 Cytomegalovirus vaccines 1032
Mark R. Schleiss, Stanley A. Plotkin
44 Dengue vaccines 1042
Scott B. Halstead, Stephen J. Thomas
45 Diarrhea caused by bacteria 1052
James P. Nataro, Eileen M. Barry
46 Ebola vaccine 1060
Nancy J. Sullivan, Hugues F. Fausther-Bovendo, Gary J. Nabel
47 Epstein-Barr virus vaccines 1068
Viviana P. Lutzky, Denis J. Moss
48 Hepatitis C vaccines 1074
Sergio Abrignani, Eva Reali, Michael Houghton, Raffaele De Francesco
49 Hepatitis E vaccines 1085
Robert H. Purcell, Suzanne U. Emerson
50 Herpes simplex virus vaccines 1090
Lawrence R. Stanberry, Robert B. Belshe
51 Human immunodeficiency virus vaccines 1097
Marc P. Girard, Wayne C. Koff
52 Lyme disease vaccines 1122
Allen C. Steere, Ian Livey
53 Malaria vaccines 1133
W. Ripley Ballou, Joe Cohen
54 Noninfectious disease vaccines 1138
Philippe Saudan, Martin F. Bachmann
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
Ruth A. Karron
56 Parasitic disease vaccines 1154
Peter J. Hotez, Jeffrey M. Bethony
57 Staphylococcus aureus vaccines 1161
Robert S. Daum
58 Streptococcus group A vaccines 1169
Karen L. Kotloff
59 Streptococcus group B vaccines 1176
C. Mary Healy, Carol J. Baker
60 Technologies for making new vaccines 1182
Ronald W. Ellis, Rino Rappuoli, Sohail Ahmed
61 Alternative vaccine delivery methods 1200
Bruce G. Weniger, Mark J. Papania
62 The development of gene-based vectors for immunization 1232
David B. Weiner, Gary J. Nabel
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
Per Ljungman
64 Vaccination of human immunodeficiency virus-infected persons 1257
William J. Moss, Catherine G. Sutcliffe, Neal A. Halsey
65 Vaccines for international travel 1270
Elizabeth D. Barnett, Phyllis E. Kozarsky, Robert Steffen
66 Vaccines for health care personnel 1290
David J. Weber, William A. Rutala
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
Lance E. Rodewald, Walter A. Orenstein, Alan R. Hinman, Anne Schuchat
68 Immunization in Europe . 1334
David M. Salisbury, Rebecca M. Martin, Pierre Van Damme, Pier Luigi Lopalco
69 Immunization in the Asia-Pacific region 1353
Theodore F. Tsai, Hans Bock, Zhi Yi Xu
70 Immunization in developing countries 1369
Violaine Mitchell, Vance J. Dietz, Jean Marie Okwo-Bele, Felicity T. Cutts
71 Community immunity 1395
Paul E. M. Fine, Kim Mulholland
72 Economic analyses of vaccine policies 1413
Mark A. Miller, Alan R. Hinman
73 Regulation and testing of vaccines 1427
Norman W. Baylor, Valerie B. Marshall
74 Regulation of vaccines in Europe 1447
Falk Ehmann, Xavier Kurz, Marco Cavaleri, Peter R. Arlett
75 Regulation of vaccines in developing countries 1454
Lahouari Belgharbi, Nora Dellepiane, David J. Wood
76 Vaccine safety 1464
Paul A. Offit, Frank DeStefano
77 Legal issues . 1481
Geoffrey Evans, Emily Marcus Levine, Anna L. Jacobs
78 Ethics 1508
Arthur L. Caplan, Jason L. Schwartz
Appendix 1514
Deborah L. Wexler, Teresa A. Anderson, Mary R. Quirk
Index .1521